GENE ONLINE|News &
Opinion
Blog

GRAIL
M&A Illumina
European Commission Prohibits Illumina’s Acquisition of GRAIL After The Company’s Win Against The FTC
2022-09-07
M&A Best of 2021
GeneOnline’s Top 10 M&As of 2021
2022-01-11
M&A Federal Trade Commission
Illumina Completes GRAIL Acquisition Without Approval From FTC
2021-08-19
Trials & Approvals Cancer
NHS To Trial GRAIL’s Blood Test That Can Accurately Detect Over 50 Cancers at Early Stages
2021-07-01
Ranking & Reports Precision Oncology
10 Precision Oncology Companies to Look Out for
2021-05-27
M&A
Amidst Battle with FTC, Illumina Faces Scrutiny from EU Over its $7.1B GRAIL Merger
2021-04-20
M&A
FTC Blocks Illumina’s $7 Billion Acquisition Bid to Restrict Monopoly of Cancer Diagnostic Market
2021-04-01
Special COVID-19
GeneOnline’s Top Mergers and Acquisitions of 2020
2020-12-30
M&A Cancer
Illumina Advances Talks to Acquire Healthcare Start-up Grail
2020-09-16
IPO Cancer
Cancer-Screening Startup GRAIL Files for IPO
2020-09-12
LATEST
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Singapore’s NUS Medicine Launches Centre for Sustainable Medicine
2023-11-20
READ MORE
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top